ODTC — Odonate Share News
0.000.00%
HealthcareSpeculativeMicro Cap
U.S. STOCKS ON THE MOVE-Gold miners, chip stocks, General Mills
Brief: Odonate Therapeutics Says Offering Of Common Shares Priced At $26/Share
Odonate Therapeutics: Falls after pricing upsized stock deal
Brief: Odonate Therapeutics Announces Public Offering Of Shares Of Common Stock
Brief: Odonate Therapeutics Announces Financial Results For The Three Months Ended March 31, 2019
Brief: Odonate Therapeutics Announces Initiation Of Contessa 2 Study Of Tesetaxel
Brief: Odonate Therapeutics Q4 Loss Per Share $1.17
Brief: Odonate TherapeuticsFiles For Stock Offering Of Upto $150 Mln
Brief: Odonate Therapeutics - Promoted John Lemkey To COO
Brief: Odonate Therapeutics Q3 Loss Per Share $0.98
Brief: Odonate Therapeutics Qtrly Loss Per Share $0.79
Brief: Odonate Therapeutics Qtrly Loss Per Share $0.69
Brief: Odonate Therapeutics Q4 Loss Per Share $0.81
Brief: Odonate Therapeutics Announces Initiation Of CONTESSA, A Phase 3 Study Of Tesetaxel In Patients With Locally Advanced Or Metastatic Breast Cancer
Brief: Odonate Holdings Llc Reports A 11.5 Pct Stake In Odonate Therapeutics As Of Dec 6
Brief: Boxer Capital LLC Reports 10.0 Pct Stake In Odonate Therapeutics As Of Dec 6
Brief: Odonate Therapeutics Announces Pricing Of Initial Public Offering